Biogen Inc’s recent filing unveils that its Head of Development Singhal Priya unloaded Company’s shares for reported $17293.0 on Dec 09 ’24. In the deal valued at $157.21 per share,110 shares were sold. As a result of this transaction, Singhal Priya now holds 5,426 shares worth roughly $0.77 million.
Then, Singhal Priya bought 110 shares, generating $17,293 in total proceeds.
Before that, Singhal Priya sold 431 shares. Biogen Inc shares valued at $88,019 were divested by the Head of Development at a price of $204.22 per share. As a result of the transaction, Singhal Priya now holds 5,316 shares, worth roughly $0.76 million.
Piper Sandler downgraded its Biogen Inc [BIIB] rating to a Neutral from a an Overweight in a research note published on January 02, 2025; the price target was decreased to $138 from $315. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who decreased its forecast for the stock in mid December from “an Outperform” to “a Market perform”. Stifel also remained covering BIIB and has decreased its forecast on December 16, 2024 with a “Hold” recommendation from previously “Buy” rating.
Price Performance Review of BIIB
On Tuesday, Biogen Inc [NASDAQ:BIIB] saw its stock jump 0.11% to $142.49. Over the last five days, the stock has lost -2.06%. Biogen Inc shares have fallen nearly -6.82% since the year began. Nevertheless, the stocks have fallen -42.50% over the past one year. While a 52-week high of $246.44 was reached on 01/07/25, a 52-week low of $139.71 was recorded on 01/22/25. SMA at 50 days reached $150.87, while 200 days put it at $192.25.
Levels Of Support And Resistance For BIIB Stock
The 24-hour chart illustrates a support level at 141.05, which if violated will result in even more drops to 139.60. On the upside, there is a resistance level at 143.96. A further resistance level may holdings at 145.42. The Relative Strength Index (RSI) on the 14-day chart is 39.97, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.65, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.08%. Stochastics %K at 30.71% indicates the stock is a holding.
How much short interest is there in Biogen Inc?
A steep rise in short interest was recorded in Biogen Inc stocks on 2025-01-15, growing by 1.19 million shares to a total of 3.77 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 2.58 million shares. There was a rise of 31.65%, which implies that there is a positive sentiment for the stock.
